Business
Compass Therapeutics to Participate in Upcoming June Investor Events
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of June. Details are as follows: Jefferies Global Healthcare ConferenceDate: Thursday, June 4, 2026 Time: 8:45 AM ETWebcast Link: https://cmpx.info/jefferies Goldman Sach
About this update from Compass Therapeutics, Inc.
[{"type":"image","alt":"Compass Therapeutics","displaySize":"","headline":null,"caption":"Compass Therapeutics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":78,"url":"https://media.zenfs.com/en/globenewswire.com/24acefcca952f8de468624053ca6bd5b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/e0q.NZaC1.yytJcmIgZeZA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwOQ--/https://media.zenfs.com/en/globenewswire.com/24acefcca952f8de468624053ca6bd5b","width":300,"height":78},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/e0q.NZaC1.yytJcmIgZeZA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwOQ--/https://media.zenfs.com/en/globenewswire.com/24acefcca952f8de468624053ca6bd5b","width":300,"height":78}},"lazy":false},{"type":"text","content":"BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of June.","length":338,"tagName":"p"},{"type":"text","content":"Details are as follows:","length":23,"tagName":"p"},{"type":"text","content":"Jefferies Global Healthcare ConferenceDate: Thursday, June 4, 2026 Time: 8:45 AM ETWebcast Link: https://cmpx.info/jefferies","length":127,"tagName":"p"},{"type":"text","content":"Goldman Sachs 47th Annual Global Healthcare ConferenceDate: Tuesday, June 9, 2026 Time: 8:00 AM ETWebcast Link: https://cmpx.info/gs","length":135,"tagName":"p"},{"type":"text","content":"Virtual/Replay availability: Presentations will be archived on Compass’ Events page.","length":99,"tagName":"p"},{"type":"text","content":"Compass’ management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings.","length":170,"tagName":"p"},{"type":"text","content":"About Compass TherapeuticsCompass Therapeutics, Inc. was founded in 2014 and is headquartered in Boston, MA. Compass is a clinical-stage, oncology-focused biopharmaceutical company discovering and developing proprietary antibody-based therapeutics to treat multiple diseases. The company’s scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. Compass has a ro...